How is the Cardiac Biomarkers Testing Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the cardiac biomarkers testing market?
In recent years, the cardiac biomarkers testing market has seen substantial growth. An increase from $13.48 billion in 2024 to an expected $15.09 billion in 2025, at a 12.0% compound annual growth rate (CAGR), is projected. The historic growth trajectory can be traced back to factors such as the rise in cardiovascular diseases, an aging demographic, awareness and education efforts, governmental actions and health policies, and escalated healthcare spending.
What will be the cardiac biomarkers testing market size in the future?
The market size for cardiac biomarkers testing is projected to experience substantial growth in the coming years, with its value expected to reach $23.75 billion in 2029, growing at a compound annual growth rate of 12.0%. This expected growth could be due to the advent of personalized medicine, an increasing global prevalence of cardiovascular diseases, the integration of artificial intelligence into diagnostics, the expansion of point-of-care testing, and a growing emphasis on early detection of diseases. Key trends expected during the forecast period include technological innovations, progress in AI-supported diagnostics, an expansion in point-of-care testing, enhanced multiplexing capabilities, and progress in biomarker discovery and validation.
Get your cardiac biomarkers testing market report here!
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
What main drivers are fueling expansion in the cardiac biomarkers testing market?
The escalating occurrence of cardiovascular ailments is projected to propel the expansion of the cardiac biomarkers testing market in future. These diseases mainly impact the heart or blood vessels. The role of cardiac biomarker tests is to ascertain the concentration of biomarkers, which helps in promptly establishing the intensity and scale of a heart attack. Hence, an upswing in cardiovascular disease cases will result in a surge in demand for cardiac biomarker testing solutions. For example, the American College of Cardiology, a professional medical establishment based in the US, predicted in August 2022 that the rates of cardiovascular risk factors and disease could significantly escalate within the country by 2060. Consequently, the growing prevalence of cardiovascular diseases is catalyzing the growth of the cardiac biomarkers testing market.
What key areas define the segmentation of the global cardiac biomarkers testing market?
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
Who are the dominant players expanding their reach in the cardiac biomarkers testing market?
Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
How are evolving market trends shaping cardiac biomarkers testing Strategies?
Prominent firms in the cardiac biomarker testing industry are forming strategic alliances to offer tech for detecting early symptoms of heart-related conditions and enhancing patient results. Collaborations via strategic alliances in cardiac biomarker testing boosts innovation in diagnostics, broadens market presence, and hastens the rollout of cutting-edge testing solutions, ensuring better cardiovascular care. For example, in September 2024, MediBuddy, an Indian health tech firm offering a broad platform for telehealth services, health administration, and insurance help, forged a partnership with Philips, a Dutch conglomerate. The goal of this partnership is to boost cardiac care in India by integrating Philips’ HeartPrint technology, which enables consistent monitoring and risk evaluation of heart health. This forward-looking strategy equips MediBuddy platform users with high-end tools, fostering preemptive management of heart health and ensuring better results.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436
Which regions are emerging as leaders in the cardiac biomarkers testing market?
North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Interventional Cardiology Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Cardiovascular Medical Lasers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
